FOXC1 and breast carcinoma: The FOXC1 methylation status might be a widely applicable prognostic factor for breast cancer patients while the methylation status of ABCB1 and GSTP1 might be a predictive factor for doxorubicin and perhaps anthracycline treatment in general.